(Q33839338)

29 July 2017

Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

1 reference

Ralf Weigel

11

0 references

Mina C Hosseinipour

2

object named as

Mina C Hosseinipour

1 reference

29 July 2017

10

Charles Mwansambo

1 reference

29 July 2017

12

Peter Kazembe

1 reference

29 July 2017

Amanda H Corbett

1

1 reference

29 July 2017

Jean Nyirenda

3

1 reference

29 July 2017

Cecelia Kanyama

4

1 reference

29 July 2017

Naser L Rezk

5

1 reference

29 July 2017

Pax Mkupani

6

1 reference

29 July 2017

Dorothy Sichali

7

1 reference

29 July 2017

Hsiao Tien

8

1 reference

29 July 2017

Angela Dm Kashuba

9

1 reference

29 July 2017

1 January 2010

1 reference

29 July 2017

1 reference

29 July 2017

15

1 reference

29 July 2017

1

1 reference

29 July 2017

83-90

1 reference

Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

Effectiveness of generic fixed-dose combinations of highly active antiretroviral therapy for treatment of HIV infection in India

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

Analysis of generic nevirapine products in developing countries

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

Pharmacokinetics, safety, and activity of nevirapine in human immunodeficiency virus type 1-infected children

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2867092

Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20167994

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20167994

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3851/IMP1488

1 reference

29 July 2017

1 reference

29 July 2017

1 reference